Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Attenuation of hyperinsulinemia in polycystic ovary syndrome: what are the options?

× No keyword cloud information.

34 in total

1. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

Authors: E Velázquez; A Acosta; S G Mendoza
Journal: Obstet Gynecol Date: 1997-09 Impact factor: 7.661

Review 2. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

Authors: D A Ehrmann; R B Barnes; R L Rosenfield
Journal: Endocr Rev Date: 1995-06 Impact factor: 19.871

Review 3. Thiazolidinediones in the treatment of insulin resistance and type II diabetes.

Authors: A R Saltiel; J M Olefsky
Journal: Diabetes Date: 1996-12 Impact factor: 9.461

4. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.

Authors: M S Wu; P Johnston; W H Sheu; C B Hollenbeck; C Y Jeng; I D Goldfine; Y D Chen; G M Reaven
Journal: Diabetes Care Date: 1990-01 Impact factor: 19.112

Review 5. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors: A Dunaif
Journal: Endocr Rev Date: 1997-12 Impact factor: 19.871

Review 6. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome.

Authors: R L Rosenfield; R B Barnes; J F Cara; A W Lucky
Journal: Fertil Steril Date: 1990-05 Impact factor: 7.329

7. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.

Authors: E M Velazquez; S Mendoza; T Hamer; F Sosa; C J Glueck
Journal: Metabolism Date: 1994-05 Impact factor: 8.694

Attenuation of hyperinsulinemia in polycystic ovary syndrome: what are the options?